Click to set custom HTML
RECENTLY PUBLISHED PAPERS
MRI and Quantitative Magnetic Susceptibility Maps of the Brain after Serial Administration of Gadobutrol: A Longitudinal Follow-up Study
Detection and imaging of gadolinium accumulation in human bone tissue...
Bone tissue is metabolically active & continually undergoes remodelling ... Slow endogenous Gd release into the bloodstream is likely to occur & the risk is even higher in subjects with increased bone resorption (pregnancy, lactation, during menopause; in osteoporotic patients)"
Presence of other rare earth metals in gadolinium-based contrast agents
Although the RE are chemically similar, the other RE do not perform as Gd as a contrast agent; therefore, their presence in formulations may be a matter of concern."
Evaluation of Toxicity of Gadolinium-Based Contrast Agents on Neuronal Cells
Brain tissue gadolinium retention in pediatric patients after contrast-enhanced magnetic resonance exams: pathological confirmation
Gadolinium Retention in Erythrocytes and Leukocytes From Human and Murine Blood Upon Treatment With Gadolinium-Based Contrast Agents for Magnetic Resonance Imaging
Gadolinium-Based Contrast Agents: Stimulators of Myeloid-Induced Renal Fibrosis and Major Metabolic Disruptors
Gadolinium aggregates in the lysosomes of vital organs, such as the kidneys."
Gadolinium-Based MRI Contrast Agents Induce Mitochondrial Toxicity and Cell Death in Human Neurons
"For all GBCAs, cell death increased with exposure dose…”
Nonhomogeneous Gadolinium Retention in the Cerebral Cortex after Intravenous Administration of Gadolinium-based Contrast Agent in Rats and Humans
Urinary Gadolinium Levels After Contrast-Enhanced MRI in Individuals with Normal Renal Function
The Dark Side of Gadolinium: A Study of Arthrographic Contrast at Extreme Concentrations
Gadolinium-Based Contrast Agents: Why Nephrologists Need To Be Concerned
The Need for National Guidance Around Informed Consent About GBCA Safety
Quantitative Analysis of Gd in The Protein Content of The Brain Following Single Injection of (GBCAs)...
Gadolinium-Based Contrast Agents: A Clinically Significant Analytical Interference in ICP-MS Elemental Analysis
‘Nephrogenic’ Systemic Fibrosis is Mediated by Myeloid C-C Chemokine Receptor 2
The Gadolinium Hypothesis for Fibromyalgia And Unexplained Widespread Chronic Pain
Signal Hyperintensity on Unenhanced T1-Weighted Brain and Cervical Spinal Cord MR Images after Multiple Doses of Linear Gadolinium-Based Contrast Agent
Gadolinium Deposition in The Brain: Current Knowledge and Recommendations
suspended at least in Europe, there is no doubt that repeating administration of macrocyclic GBCA could also lead to Gd deposition in brain parenchyma"
Gadolinium Enhancement of the Aneurysm Wall in Unruptured Intracranial Aneurysms Is Associated with an Increased Risk of Aneurysm Instability: A Follow-Up Study
Anthropogenic gadolinium in freshwater and drinking water systems
Establishing Reference Intervals for Gadolinium Concentrations in Blood, Plasma, and Urine in Individuals Not Previously Exposed to Gadolinium-Based Contrast Agents
MAYO CLINIC'S REFERENCE RANGE
For the purposes of this review, detection of gadolinium weeks or months following GBCA administration is considered abnormal as gadolinium is a trace element and not involved in any physiologic processes; the levels of gadolinium in the body considered normal in the absence of any GBCA exposure is, for practical purposes, zero." FDA Medical Imaging Drugs Advisory Committee Meeting, Briefing Doc pg. 16, September 8, 2017
A scientific attitude is of great importance, but we must recognize that science has absolutely nothing to do with the 'consensus of the authorities.' You are less likely to do the wrong thing if you believe that 'the authorities are always wrong because then you will begin to question their assumptions, evaluate their evidence, & examine their reasoning. Dr.Ray Peat